Cargando…

NLRP-3 Inflammasome: A Key Target, but Mostly Overlooked following SARS-CoV-2 Infection

Detalles Bibliográficos
Autor principal:	Sergi, Consolato M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413552/ https://www.ncbi.nlm.nih.gov/pubmed/36016195 http://dx.doi.org/10.3390/vaccines10081307

Ejemplares similares

Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein
por: Yalcinkaya, Mustafa, et al.
Publicado: (2021)

SAMHD1 as the Potential Link Between SARS-CoV-2 Infection and Neurological Complications
por: Khan, Aiza, et al.
Publicado: (2020)

SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation
por: Pan, Pan, et al.
Publicado: (2021)

The NLRP3-Inflammasome in Health and Disease
por: Perri, Anna
Publicado: (2022)

Cystic Fibrosis Lung Disease and Immunometabolism. Targeting the NLRP3 Inflammasome
por: Cantin, André M.
Publicado: (2019)

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
por: Albornoz, Eduardo A., et al.
Publicado: (2022)

Nanosponges: An overlooked promising strategy to combat SARS-CoV-2
por: Mostafavi, Ebrahim, et al.
Publicado: (2022)

Implications of the Emerging SARS-CoV-2 Variant: Caution is the Key
por: Al Awaidy, Salah T., et al.
Publicado: (2021)

Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
por: Guan, Yadi, et al.
Publicado: (2020)

Inflammasomes and SARS-CoV-2 Infection
por: Kaivola, Juha, et al.
Publicado: (2021)

SARS-CoV-2 Nonstructural Proteins 1 and 13 Suppress Caspase-1 and the NLRP3 Inflammasome Activation
por: Kim, Na-Eun, et al.
Publicado: (2021)

Author Correction: SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation
por: Pan, Pan, et al.
Publicado: (2021)

Postacute sequelae of SARS-CoV-2 infection. Osteonecrosis must not be overlooked
por: Koutalos, Antonios A., et al.
Publicado: (2022)

Role of NLRP3 inflammasome in inflammatory bowel diseases
por: Tourkochristou, Evanthia, et al.
Publicado: (2019)

Fatty acid synthesis and NLRP3-inflammasome
por: Moon, Jong-Seok, et al.
Publicado: (2015)

Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients
por: Lara, Pedro C, et al.
Publicado: (2020)

SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release
por: Junqueira, Caroline, et al.
Publicado: (2021)

Saturated fatty acid-crystals activate NLRP3 inflammasome
por: Karasawa, Tadayoshi, et al.
Publicado: (2019)

Fyn amplifies NLRP3 inflammasome signaling in Parkinson's disease
por: Panicker, Nikhil, et al.
Publicado: (2019)

Targeting the NLRP3 Inflammasome in Glaucoma
por: Coyle, Sophie, et al.
Publicado: (2021)

NLRP3 Inflammasome—A Key Player in Antiviral Responses
por: Zhao, Chunyuan, et al.
Publicado: (2020)

SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway
por: Campbell, Grant R., et al.
Publicado: (2021)

SARS-CoV-2 variant-dependent inflammasome activation
por: Teyssou, Elisa, et al.
Publicado: (2023)

The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases
por: Cama, Viviana Falcón, et al.
Publicado: (2021)

The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection
por: Lécuyer, Déborah, et al.
Publicado: (2023)

SARS-CoV-2 Papain-like Protease Negatively Regulates the NLRP3 Inflammasome Pathway and Pyroptosis by Reducing the Oligomerization and Ubiquitination of ASC
por: Meng, Huan, et al.
Publicado: (2023)

Targeting the NLRP3 Inflammasome via BTK
por: Weber, Alexander N. R.
Publicado: (2021)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

SARS-CoV-2 docet
por: Sarli, Leopoldo
Publicado: (2021)

Promptly reporting of critical laboratory values in pediatrics: A work in progress
por: Sergi, Consolato
Publicado: (2018)

Who is most likely to be infected with SARS-CoV-2?
por: Jordan, Rachel E, et al.
Publicado: (2020)

NLRP3 Inflammasome: Key Mediator of Neuroinflammation in Murine Japanese Encephalitis
por: Kaushik, Deepak Kumar, et al.
Publicado: (2012)

Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents
por: Ayaz, Sameer, et al.
Publicado: (2020)

Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
por: de Marco, Ario, et al.
Publicado: (2022)

SARS-CoV-2-induced senescence as a potential therapeutic target
por: Denholm, Mary, et al.
Publicado: (2022)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

On the importance of population-based serological surveys of SARS-CoV-2 without overlooking their inherent uncertainties
por: Kritsotakis, Evangelos I.
Publicado: (2020)

On the Road Back to Normalcy: Following Science Over Noise in SARS-CoV-2
por: Shah, Sadia Z., et al.
Publicado: (2021)

SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine “storm” and risk factor for damage of hematopoietic stem cells
por: Ratajczak, Mariusz Z., et al.
Publicado: (2020)

Pediatrics: An Evolving Concept for the 21st Century
por: Sergi, Consolato M.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uon54rp2rr7ug1d0coooi90g0o